Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if RANI is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
14 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: buy 83 days ago
Red flags: 3
67 filers reported a long position in RANI for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Samsara BioCapital, LLC | $7.9M | 10.4M | +22% |
| RA CAPITAL MANAGEMENT, L.P. | $6.5M | 8.5M | Unchanged |
| AWM Investment Company, Inc. | $5.7M | 7.5M | +15.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.5M | 4.6M | -1.3% |
| Longaeva Partners L.P. | $1.8M | 2.3M | Unchanged |
| Polar Asset Management Partners Inc. | $1.8M | 2.3M | New |
| Siren, L.L.C. | $1.5M | 2M | Unchanged |
| HEIGHTS CAPITAL MANAGEMENT, INC | $710.7K | 934.6K | New |
| GEODE CAPITAL MANAGEMENT, LLC | $677.6K | 890.6K | -1.4% |
| CITADEL ADVISORS LLC | $488.2K | 642K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.